Gossamer Bio
Price & Volume
Stats
See more52W Range | $0.32-$3.87 |
Market Cap | $96.1M |
Shares Short | 37M |
Financials
See moreRevenue (12 Mos) | $48.4M |
Revenue Growth (YoY) | 47.1% |
Gross Profit (12 Mos) | $48.4M |
Diluted EPS | -$0.75 |
News
See moreYahoo Finance • 6 hours ago
Analysts Remain Bullish on Gossamer Bio (GOSS) Despite Phase 3 Setback
Yahoo Finance • 2 days ago
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Yahoo Finance • 2 days ago
DEADLINE ALERT for GOSS, NUAI, MEDP, and STLA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Yahoo Finance • 6 days ago
Cantor Fitzgerald Downgrades Gossamer Bio (GOSS) to Neutral
About
CEO | Mr. Faheem Hasnain |
CFO | Mr. Bryan Giraudo |
Address | 3115 Merryfield Row, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |
